Hodgkin's lymphoma market size is expected to increase during the forecast period (2025–2034) owing to increasing incidence, advancements in ...

An expert discusses that this case of a 60-year-old man with primary refractory diffuse large B-cell lymphoma highlights the ...

Brentuximab vedotin combined with cyclophosphamide, doxorubicin, and prednisone (CHP) shows promising results as a first-line ...

The first sign of multiple myeloma varies by person and may not occur until a later stage of the disease. Learn how to ...

The small change that could ease symptoms for blood cancer patients - Exercise is good for everyone, but for people living with chronic lymphocytic leukaemia, it can be life-changing ...